Ke Cheng
Founder and CEO, HISTOWIZ, USA
Biography
Ke has over 10 years of experience in mouse histopathology and cancer research. She finished her PhD in Cancer Biology from Pier Paolo Pandolfi's lab at Harvard and led a team of investigators to publish papers in journals such as Nature and Blood. Prior to founding HistoWiz, she worked at a cancer diagnostics company (NASDAQ: CGIX) and did a postdoctoral fellowship with Douglas Hanahan at the Swiss Institute of Experimental Cancer Research.
Abstract
Abstract : At the intersection of biology and computer science: Machine learning of histopathology